'Investigator commentary' presentation slideshows

1 Komrokji RS et al. Proc ASH 2011;Abstract 282.

225 views • 17 slides

Eichhorst B et al. Proc ASH 2013;Abstract 526.

205 views • 11 slides

Romond EH et al. Proc SABCS 2012;Abstract S5-5.

Trastuzumab plus Adjuvant Chemotherapy for HER2-Positive Breast Cancer: Final Planned Joint Analysis of Overall Survival from NSABP B-31 and NCCTG N9831. Romond EH et al. Proc SABCS 2012;Abstract S5-5. Background.

342 views • 10 slides

206 views • 9 slides

Radford J et al. Proc ASH 2012;Abstract 547.

284 views • 9 slides

Cunningham D et al. Proc ASCO 2011;Abstract 8000.

A Phase III Trial Comparing R-CHOP 14 and R-CHOP 21 for the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma. Cunningham D et al. Proc ASCO 2011;Abstract 8000. Phase III Trial of R-CHOP 14 versus R-CHOP 21 in DLBCL. R-CHOP 21 (n = 540) CHOP 21 x 8 cycles Rituximab x 8 cycles. R*.

242 views • 6 slides